umc119-06-05
Cell therapyexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 31, 2021 (NCT04914403)
Timeline
Indications
Mechanism of action
- Stem CellSupplementation
Stem Cell supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06491043 | Phase 2 | Jun 11, 2024 | Meribank Biotech Co., Ltd. |
| NCT04893174 | Phase 1 | Jan 31, 2022 | Meridigen Biotech Co., Ltd. |
| NCT04914403 | Phase 1 | Jul 31, 2021 | Meridigen Biotech Co., Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Meridigen Biotech Co., Ltd. | For profit | 2 | 2 | 1 | 2021 |
| Meribank Biotech Co., Ltd. | For profit | 1 | 1 | 1 | 2024 |
2 organizations
Page 1 / 1